For Immediate Release
Newly Appointed Editor-in-Chief and Expanded Scope for Journal of Caffeine Research
New Rochelle, NY, August 11, 2017-- Mary Ann Liebert, Inc., publishers is pleased to announce Sergi Ferré, MD, PhD, has been appointed Editor-in-Chief of Journal of Caffeine Research. Dr. Sergi Ferré serves as a senior investigator and chief of the Integrative Neurobiology Section at the National Institute on Drug Abuse. We are pleased to welcome Dr. Ferré to Journal of Caffeine Research which will be retitled to Journal of Caffeine and Adenosine Research starting January 1, 2018.
Journal of Caffeine Research covers the effects of caffeine on a wide range of diseases and conditions, including mood disorders, neurological disorders, cognitive performance, cardiovascular disease, and sports performance. Journal of Caffeine Research explores all aspects of caffeine science including the biochemistry of caffeine; its actions on the human body; benefits, dangers, and contraindications; and caffeine addiction and withdrawal, across all stages of the human life span from prenatal exposure to end-of-life. The Journal will be retitled to Journal of Caffeine and Adenosine Research in January 2018. Complete information is available on the Journal of Caffeine Research website.
Mary Ann Liebert, Inc., publishers is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including Cannabis and Cannabinoid Research, The Journal of Alternative and Complementary Medicine, and Journal of Child and Adolescent Psychopharmacology. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry’s most widely read publication worldwide. A complete list of the firm’s 80 journals, books, and newsmagazines is available on the Mary Ann Liebert, Inc., publishers website.